Zsuzsa Bodgal
Papers
1
Total Citations
5
H-Index
1
About
Dr. Zsuzsa Bodgal is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for prostate cancer. Her major contribution lies in pioneering less invasive, high-precision treatment paradigms that prioritize patients’ quality of life without compromising oncological control. Her landmark Phase-II trial, published in 2023, demonstrated that stereotactic focal radiotherapy offers a compelling alternative to active surveillance for low-risk prostate cancer, achieving excellent tumor control while sparing healthy tissue and minimizing side effects. This work has already garnered significant attention, with 5 citations in its first year, signaling its rapid impact on clinical guidelines. Dr. Bodgal’s research directly addresses the critical dilemma in low-risk prostate cancer management: balancing the need for treatment against the desire to preserve quality of life. By validating a non-radical, ultra-focused approach, she is reshaping the standard of care, offering patients a middle path between watchful waiting and aggressive therapy. Her ongoing work continues to refine patient selection and dosimetry, cementing her reputation as a key innovator in the field of precision oncology.
Research Focus
Key Achievements
Top Papers
- 1